Invention Grant
- Patent Title: Protease-activated T cell bispecific molecules
-
Application No.: US16138417Application Date: 2018-09-21
-
Publication No.: US11242390B2Publication Date: 2022-02-08
- Inventor: Peter Bruenker , Rebecca Croasdale-Wood , Christian Klein , Juergen Michael Schanzer , Kay-Gunnar Stubenrauch , Pablo Umana , Martina Geiger , Eric Sullivan , Jigar Patel
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agency: Clark & Elbing LLP
- Agent Karen L. Elbing
- Priority: EP16161740 20160322
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; C07K16/42 ; A61K39/00

Abstract:
The present invention generally relates to novel protease-activatable T cell activating bispecific molecules and idiotype-specific polypeptides. The present invention also relates to polynucleotides encoding such protease-activatable T cell activating bispecific molecules and idiotype-specific polypeptides, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the protease-activatable T cell activating bispecific molecules and idiotype-specific polypeptides of the invention, and to methods of using these protease-activatable T cell activating bispecific molecules and idiotype-specific polypeptides in the treatment of disease.
Public/Granted literature
- US20190119383A1 PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES Public/Granted day:2019-04-25
Information query